{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:57:57Z","timestamp":1793127477082,"version":"4.5.0"},"reference-count":27,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2013,11,14]],"date-time":"2013-11-14T00:00:00Z","timestamp":1384387200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0080705","type":"journal-article","created":{"date-parts":[[2013,11,14]],"date-time":"2013-11-14T22:48:40Z","timestamp":1384469320000},"page":"e80705","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":174,"title":["Loss of Leucine-Rich Repeat Kinase 2 (LRRK2) in Rats Leads to Progressive Abnormal Phenotypes in Peripheral Organs"],"prefix":"10.1371","volume":"8","author":[{"given":"Marco A. S.","family":"Baptista","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuldip D.","family":"Dave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Frasier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd B.","family":"Sherer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Greeley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa J.","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie S.","family":"Varsho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George A.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline J.","family":"Churchill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles K.","family":"Meshul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian K.","family":"Fiske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,11,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"e66164","DOI":"10.1371\/journal.pone.0066164","article-title":"Leucine-Rich Repeat Kinase 2 (LRRK2)-Deficient Rats Exhibit Renal Tubule Injury and Perturbations in Metabolic and Immunological Homeostasis","volume":"8","author":"D Ness","year":"2013","journal-title":"PLOS ONE"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/S0140-6736(09)60492-X","article-title":"Parkinson's disease","volume":"373","author":"AJ Lees","year":"2009","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.bbadis.2009.06.001","article-title":"Revelations and revolutions in the understanding of Parkinson's disease","volume":"1792","author":"TM Dawson","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","article-title":"Non-motor symptoms of Parkinson's disease: diagnosis and management","volume":"5","author":"KR Chaudhuri","year":"2006","journal-title":"Lancet Neurol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"MH Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1093\/hmg\/6.10.1687","article-title":"Genetics of Parkinson's disease","volume":"6","author":"RL Nussbaum","year":"1997","journal-title":"Hum Mol Genet"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","article-title":"Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology","volume":"44","author":"A Zimprich","year":"2004","journal-title":"Neuron"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1056\/NEJMc055509","article-title":"LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews","volume":"354","author":"LJ Ozelius","year":"2006","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/mds.21180","article-title":"Screening for Lrrk2 G2019S and clinical comparison of Tunisian and North American Caucasian Parkinson's disease families","volume":"22","author":"L Ishihara","year":"2007","journal-title":"Mov Disord"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/ana.21405","article-title":"Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease","volume":"64","author":"OA Ross","year":"2008","journal-title":"Ann Neurol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nrn2935","article-title":"The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease","volume":"11","author":"MR Cookson","year":"2010","journal-title":"Nat Rev Neurosci"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"16842","DOI":"10.1073\/pnas.0507360102","article-title":"Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity","volume":"102","author":"AB West","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1741-7015-10-20","DOI":"10.1186\/1741-7015-10-20","article-title":"Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease?","volume":"10","author":"IN Rudenko","year":"2012","journal-title":"BMC Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"9879","DOI":"10.1073\/pnas.1004676107","article-title":"Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of alpha-synuclein, and apoptotic cell death in aged mice","volume":"107","author":"Y Tong","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1750-1326-7-2","article-title":"Loss of leucine-rich repeat kinase 2 causes age-dependent bi-phasic alterations of the autophagy pathway","volume":"7","author":"Y Tong","year":"2012","journal-title":"Mol Neurodegener"},{"key":"ref16","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddr348","article-title":"LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice","author":"MC Herzig","year":"2011"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1750-1326-7-25","article-title":"LRRK2 knockout mice have an intact dopaminergic system but display alterations in exploratory and motor co-ordination behaviors","volume":"7","author":"KM Hinkle","year":"2012","journal-title":"Mol Neurodegener"},{"key":"ref18","article-title":"AFIP Method for Lipofuscin: Manual for Histologic Staining Methods of the Armed Forces","author":"LG Luna","year":"1968"},{"key":"ref19","doi-asserted-by":"crossref","DOI":"10.1080\/01926230390213775","article-title":"A fast histochemical staining method to identify hyaline droplets in the rat kidney","volume":"31","author":"EP de Rijk","year":"2003","journal-title":"Toxicol Pathol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/sj.emboj.7601511","article-title":"LAMP proteins are required for fusion of lysosomes with phagosomes","volume":"26","author":"KK Huynh","year":"2007","journal-title":"EMBO J"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/ndt\/18.3.543","article-title":"Measurement of tubular enzymuria facilitates early detection of acute renal impairment in the intensive care unit","volume":"18","author":"J Westhuyzen","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1177\/0192623309339605","article-title":"Differences in immunolocalization of Kim-1, RPA-1, and RPA-2 in kidneys of gentamicin-, cisplatin-, and valproic acid-treated rats: potential role of iNOS and nitrotyrosine","volume":"37","author":"J Zhang","year":"2009","journal-title":"Toxicol Pathol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e32919","DOI":"10.1371\/journal.pone.0032919","article-title":"Effects of subthalamic nucleus lesions and stimulation upon corticostriatal afferents in the 6-hydroxydopamine-lesioned rat","volume":"7","author":"RH Walker","year":"2012","journal-title":"PLOS ONE"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/01926230490422574","article-title":"A contemporary overview of chronic progressive nephropathy in the laboratory rat, and its significance for human risk assessment","volume":"32","author":"GC Hard","year":"2004","journal-title":"Toxicol Pathol"},{"key":"ref25","article-title":"(99 A.D.) The clinical chemistry of laboratory animals. 2","author":"WF Loeb"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/25.1.401844","article-title":"Aldose reductase and sorbitol dehydrogenase distribution in rat kidney","volume":"25","author":"CN Corder","year":"1977","journal-title":"J Histochem Cytochem"},{"key":"ref27","article-title":"LRRK2 secretion in exosomes is regulated by 14-3-3","volume":"346","author":"KB Fraser","year":"2013","journal-title":"Hum Mol Genet DDT"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0080705","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T13:00:20Z","timestamp":1540299620000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0080705"}},"subtitle":[],"editor":[{"given":"Darren\u00a0J","family":"Moore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,11,14]]},"references-count":27,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2013,11,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0080705","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,14]]}}}